Skip to main content

Medical Swabs Market to Touch USD 4.00 Billion by 2027: Rising Prevalence of Infectious Diseases to Aid in Expansion, says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, July 24, 2020 (GLOBE NEWSWIRE) — The global medical swabs market is estimated to rise remarkably on account of the increasing application of cotton for drawing infection samples from the patient by having the least possibility of contact. According to a recently published report by Fortune Business Insights titled, “Medical Swabs Market Size, Share & COVID-19 Impact Analysis, By Type (Cotton Tipped Swab, Foam Tipped Swab, Non-woven, and Others), By Application (Specimen Collection, Disinfection, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027,” the value of this market was USD 2.34 billion in 2019 and is expected to reach USD 4.00 billion by the end of 2027. The market is expected to rise at a CAGR of 6.9% between 2020 and 2027.https://www.fortunebusinessinsights.com/medical-swabs-market-103318
What is the nature of this market and who are the key players?Which segment will lead this market and why?What is the impact of COVID-19 pandemic on this market?Which are the major industry developments of this market?
Drivers & Restraints-

The increasing prevalence of COVID-19 Pandemic to Aid in Expansion of MarketSwabs have been used by the medical sector for collecting samples for research activity or for diagnosing any disease. With the use of swab, there is minimum risk of infection contraction between a patient and the sample collector. This hygiene-friendly feature stands as a key factor promoting the medical swabs market growth. Besides this, the increasing prevalence of coronavirus pandemic is further propelling the overall growth of the market. Additionally, the rise in cases of other infectious and communicable diseases will add impetus to the market in the forecast period.On the contrary, the supply shortage of sterile swabs used in testing processes during the current coronavirus pandemic may cause major hindrance to the market in the coming years. Nevertheless, the increasing number of diseases resulting in hospital stay is further propelling the demand for medical swabs, thereby creating lucrative growth opportunities for the market in the coming years.The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in fighting against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of the coronavirus outbreak across industries to help you prepare for the future.With respect to segmentation by application, the specimen collection segment earned 56.4% medical swabs market share and emerged dominant. The growth of this segment is attributed to the growing incidences of infectious and communicable diseases.
Regional Analysis-North America Dominated Market with Increasing Demand for Continuous Diagnostic ProceduresRegion-wise, the global medical swabs market is classified into Latin America, Asia Pacific, North America, and Europe. These regions are further categorized on the basis of nations. Among these, North America generated a revenue of USD 0.97 billion in the year 2019 and emerged dominant. This is accountable to the growing prevalence of infectious diseases that demand continuous diagnostic processes.  On the other side, the increasing awareness about the need to get diagnosed for infectious diseases is likely to help Europe market rise at a notable CAGR in the forecast period. Furthermore, the Asia Pacific market is likely to showcase a healthy CAGR with the increasing number of coronavirus testing facilities.
Competitive Landscape-

Puritan Medical Products will Lead Market with Robust PortfolioThe competitive landscape of the global market for medical swabs is highly fragmented in nature witnessing the presence of both small and large scale industries. The market is dominated by Puritan Medical Products on account of its robust portfolio inclusive of products as polyester swabs, non-woven swabs, cotton tipped swab, and others. Other companies operating in this market are focusing on adopting strategies that will help them expand their geographical presence to other regions.April 2020 – Origin and Stratasys entered into a joint venture for the promotion and distribution of 3D printed nasopharyngeal swabs produced by Origin.April 2020 – The launch of Q-tip, a polyester swab manufactured by Cleveland Company, was approved by the U.S. Food and Drug Administration with the objective of maximizing the production capacity for continuous supply during the coronavirus pandemic.FL MEDICAL srl (Italy, Europe)Advacare Pharma (Maharashtra, India)Puritan Medical Products (Maine, U.S)Dynarex (New York, U.S)BD (New Jersey, U.S)DLS Medical (U.K, Europe)3M (Minnesota, U.S)FL MEDICAL srl (Italy, Europe)Copan Diagnostics Inc. (Italy, Europe)OthersIntroductionMarket ScopeMarket SegmentationMarket MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsOverview: Guidelines for COVID-19 Diagnosis Using SwabNew Product LaunchPrevalence of COVID-19 DiseaseKey Industry Developments – Mergers, Acquisitions, and PartnershipsGlobal Medical Swabs Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeCotton Tipped SwabsFoam Tipped SwabsNon-wovenOthersMarket Analysis, Insights and Forecast – By ApplicationsSpecimen CollectionDisinfectionOthersMarket Analysis, Insights and Forecast – By End UserHospitals & ClinicsLaboratories & Diagnostic CentersResearch InstituteMarket Analysis, Insights and Forecast – By GeographyNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTOC Continued….!!!

Request for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/medical-swabs-market-103318COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027
Healthcare Personal Protective Equipment (PPE) Market for COVID-19, Market Size, Share & Industry Analysis, By Product (Eye & Face Protection {Safety Spectacles, Safety Goggles, Face Mask, and Face Shield}, Protective Clothing {Isolation Gowns, Coveralls, and Others}, Hand Protection/Safety Gloves, and Respiratory Protection/N95 Respirators) By Application (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2027
Disposable Medical Gloves Market Size, Share & COVID-19 Impact Analysis, By Application (Surgical and Examination), By Material (Latex and Synthetic), By Category (Powdered and Powder free) End User (Hospitals & Clinics, Diagnostic/Pathology Labs, and Others), and Regional Forecast 2020-2027
Protective Clothing Market Size, Share & Industry Analysis, By Product (Disposable and Durable), By Application (Flame Retardant Apparel, Chemical Defending Garment {Radiation Protection, Particulate Matter, and Others}, Clean Room Clothing, Mechanical Protective Clothing, and Others), By End-Use (Pharmaceutical, Oil & Gas, Chemical, Firefighters, and Others), and Regional Forecast, 2020-2027
Protective Face Mask Market Size, Share & COVID-19 Impact Analysis, By Type (Medical Face Mask {Surgical & Procedure, N-95 Respirators, and Others}, Respirator, and Others), By Usage (Disposable, and Reusable), and By End-Use (Healthcare, Oil & Gas, Mining, Construction, Manufacturing, and Others) and Regional Forecast, 2020-2027
Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027Sleep Apnea Devices Market Size, Share & Covid-19 Impact Analysis, By Device Type (Therapeutic Devices, and Diagnostic Devices), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2020-2027Home Infusion Therapy Market Size, Share & Covid-19 Impact Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-medical-swab-market-10119

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.